Weight Loss Peptides

Weight loss peptides is our broadest metabolic collection. Alongside the GLP-1 family it includes compounds that reach energy balance through other routes: AOD-9604 for lipolysis, MOTS-c for mitochondrial energy sensing and setmelanotide for the MC4R appetite pathway. All are supplied for laboratory research only.

Different pathways, one collection
Incretin agonists act on gut-hormone receptors. Setmelanotide works downstream of leptin in the hypothalamus. AOD-9604 is a growth hormone fragment studied for fat breakdown without raising IGF-1. MOTS-c activates AMPK, the cell’s energy sensor. Having them together makes comparison studies simpler.

How to use this page
If your work is focused on incretin receptors, the GLP-1 peptides collection is narrower. Use this page when you want to compare mechanisms across pathways.

In this collection: Semaglutide 2mg, Semaglutide 5mg, Semaglutide 10mg, Tirzepatide 5mg, Tirzepatide 10mg, Tirzepatide 30mg, Mazdutide 6mg, MOTS-c 10mg, Retatrutide 15mg, Semaglutide 12.5mg, Cagrilintide 5mg, Retatrutide 5mg, Survodutide 5mg, Setmelanotide 10mg, Cagrilintide Semaglutide Blend 3mg/3mg, AOD-9604 2mg, Semaglutide 20mg, Tirzepatide 50mg, Cagrilintide Semaglutide Blend 10mg/10mg, Retatrutide 35mg, Cagrilintide 10mg, Tirzepatide 60mg, Retatrutide 10mg, Retatrutide 60mg.

Are these peptides for human weight loss?
No. They are sold for in-vitro and animal research only and are not for human or veterinary use.

What is the difference between this and the GLP-1 collection?
GLP-1 peptides covers incretin compounds only. Weight loss peptides adds non-incretin metabolic compounds such as AOD-9604, MOTS-c and setmelanotide.

All products are sold for laboratory research use only. Not for human or veterinary use.